First comprehensive DNA study of mast cell leukemia uncovers clues that could improve therapy

Cancer researchers at Cold Spring Harbor Laboratory (CSHL) have carried out the first comprehensive study of the changes seen in the DNA of a patient with mast cell leukemia (MCL), an extremely aggressive subtype of acute myeloid leukemia (AML) with a very poor prognosis.

Read the whole article on Physorg

More from Physorg